Nephros (OTCMKTS:NEPH) will issue its quarterly earnings data after the market closes on Thursday, November 8th.
Nephros (OTCMKTS:NEPH) last issued its earnings results on Wednesday, August 8th. The company reported ($0.01) earnings per share (EPS) for the quarter. Nephros had a negative net margin of 31.84% and a negative return on equity of 151.01%. The company had revenue of $1.37 million during the quarter.
Shares of Nephros stock traded up $0.01 during trading hours on Friday, hitting $0.65. The company had a trading volume of 600 shares, compared to its average volume of 14,804. Nephros has a twelve month low of $0.38 and a twelve month high of $0.73. The company has a debt-to-equity ratio of 0.21, a quick ratio of 3.18 and a current ratio of 4.15.
Nephros Company Profile
Nephros, Inc, a commercial stage medical device and commercial product company, develops and sells liquid purification filters and hemodiafiltration (HDF) systems primarily in the United States. The company's ultrafilters are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from water borne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
See Also: Do stock splits help investors?
Receive News & Ratings for Nephros Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nephros and related companies with MarketBeat.com's FREE daily email newsletter.